Detalhe da pesquisa
1.
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood
; 141(15): 1802-1811, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603187
2.
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Blood
; 142(24): 2069-2078, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556734
3.
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
Pediatr Blood Cancer
; 70(11): e30609, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553297
4.
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Pediatr Blood Cancer
; : e30467, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259259
5.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer
; 128(9): 1863-1870, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201611
6.
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Blood
; 136(2): 210-223, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219444
7.
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia.
Haematologica
; 107(8): 1746-1757, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937317
8.
Activation of the mitogen-activated protein kinase-extracellular signal-regulated kinase pathway in childhood B-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(10): e29771, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593589
9.
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Blood
; 134(15): 1227-1237, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350265
10.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica
; 106(1): 46-55, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32001530
11.
Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.
Pediatr Blood Cancer
; 68(12): e29256, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302704
12.
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
Pediatr Blood Cancer
; 68(3): e28843, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338306
13.
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
Blood
; 131(12): 1350-1359, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284596
14.
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Blood
; 131(9): 995-999, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305553
15.
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood
; 132(8): 815-824, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997224
16.
Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(7): e28306, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32391957
17.
From Favorable Histology to Relapse: The Clonal Evolution of a Wilms Tumor.
Pediatr Dev Pathol
; 23(2): 167-171, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31526128
18.
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Br J Haematol
; 186(2): 274-285, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957229
19.
Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.
Blood
; 129(14): 1919-1926, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153823
20.
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
Blood
; 129(25): 3352-3361, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408464